H. Petroková

发表

Novel high‐affinity binders of human interferon gamma derived from albumin‐binding domain of protein G

Jiří Vondrášek, Petr Malý, Lada Biedermannová, 2012, Proteins.

Novel binders derived from an albumin-binding domain scaffold targeting human prostate secretory protein 94 (PSP94)

R. Osicka, M. Kuchař, H. Petroková, 2015, Protein & Cell.

Crystallization and Preliminary X-ray Diffraction Analysis of Cold-Active β-Galactosidase from Arthrobacter sp. C2-2

J. Hašek, V. Spiwok, P. Lipovová, 2005 .

Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit

B. Strukelj, V. Hodnik, G. Anderluh, 2016, PloS one.

Cold-active β-galactosidase from Arthrobacter sp. C2-2 forms compact 660 kDa hexamers : Crystal structure at 1.9 Å resolution

J. Hašek, V. Spiwok, P. Lipovová, 2005 .

Targeting Human Thrombus by Liposomes Modified with Anti-Fibrin Protein Binders

M. Kuchař, H. Petroková, P. Malý, 2019, Pharmaceutics.

Myomedin replicas of gp120 V3 loop glycan epitopes recognized by PGT121 and PGT126 antibodies as non-cognate antigens for stimulation of HIV-1 broadly neutralizing antibodies

J. Černý, M. Kuchař, H. Petroková, 2022, Frontiers in Immunology.

A distinct binding mode of a hydroxyethylamine isostere inhibitor of HIV-1 protease.

J. Hašek, J. Konvalinka, J. Dušková, 2001, Acta crystallographica. Section D, Biological crystallography.

Increasing Affinity of Interferon-γ Receptor 1 to Interferon-γ by Computer-Aided Design

Jiří Vondrášek, Petr Malý, Jiří Černý, 2013, BioMed research international.

ABD-Derived Protein Blockers of Human IL-17 Receptor A as Non-IgG Alternatives for Modulation of IL-17-Dependent Pro-Inflammatory Axis

J. Černý, R. Osicka, M. Kuchař, 2018, International journal of molecular sciences.

p19-targeted ABD-derived protein variants inhibit IL-23 binding and exert suppressive control over IL-23-stimulated expansion of primary human IL-17+ T-cells

T. Kalina, Ondřej Pelák, J. Černý, 2017, Autoimmunity.

Human interleukin-23 receptor antagonists derived from an albumin-binding domain scaffold inhibit IL-23-dependent ex vivo expansion of IL-17-producing T-cells

J. Homola, T. Kalina, Ondřej Pelák, 2013, Proteins.

Proteins mimicking epitope of HIV-1 virus neutralizing antibody induce virus-neutralizing sera in mice

J. Černý, M. Kuchař, H. Petroková, 2019, EBioMedicine.

Myomedin scaffold variants targeted to 10E8 HIV-1 broadly neutralizing antibody mimic gp41 epitope and elicit HIV-1 virus-neutralizing sera in mice

J. Černý, J. Dušková, J. Dohnálek, 2021, Virulence.

An ethylenamine inhibitor binds tightly to both wild type and mutant HIV-1 proteases. Structure and energy study.

Pavel Majer, Jan Dohnálek, Tereza Skálová, 2003, Journal of medicinal chemistry.

Thrombus Imaging Using 3D Printed Middle Cerebral Artery Model and Preclinical Imaging Techniques: Application to Thrombus Targeting and Thrombolytic Studies

H. Petroková, P. Malý, J. Turánek, 2020, Pharmaceutics.

Cold-active beta-galactosidase from Arthrobacter sp. C2-2 forms compact 660 kDa hexamers: crystal structure at 1.9A resolution.

J. Hašek, V. Spiwok, P. Lipovová, 2005, Journal of molecular biology.

p19-Targeting ILP Protein Blockers of IL-23/Th-17 Pro-Inflammatory Axis Displayed on Engineered Bacteria of Food Origin

J. Černý, Katja Škrlec, A. Berlec, 2018, International journal of molecular sciences.

Novel binders derived from an albumin-binding domain scaffold targeting human prostate secretory protein 94 (PSP94)

R. Osicka, M. Kuchař, H. Petroková, 2015, Protein & Cell.

Role of hydroxyl group and R/S configuration of isostere in binding properties of HIV-1 protease inhibitors.

J. Hašek, J. Konvalinka, T. Skálová, 2004, European journal of biochemistry.

Hydroxyethylamine isostere of an HIV-1 protease inhibitor prefers its amine to the hydroxy group in binding to catalytic aspartates. A synchrotron study of HIV-1 protease in complex with a peptidomimetic inhibitor.

J. Hašek, J. Konvalinka, J. Dušková, 2002, Journal of medicinal chemistry.

On the role of the R configuration of the reaction-intermediate isostere in HIV-1 protease-inhibitor binding: X-ray structure at 2.0 A resolution.

J. Hašek, J. Konvalinka, T. Skálová, 2006, Acta crystallographica. Section D, Biological crystallography.

HIV-1 protease mutations and inhibitor modifications monitored on a series of complexes. Structural basis for the effect of the A71V mutation on the active site.

Jindrich Hasek, Milan Soucek, J. Hašek, 2006, Journal of medicinal chemistry.

Mutant HIV-1 protease complexed with tetrapeptide inhibitor. Preliminary report

J. Hašek, T. Skálová, J. Dohnálek, 2002 .